WMSA
SRRA

Weiss Multi-Strategy Advisers’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,648
Closed -$1.02M – 824
2022
Q2 		$1.02M Buy
+18,648
New +$979K 0.03% 482
2016
Q1 		– Sell
-250
Closed -$150K – 571
2015
Q4 		$150K Hold
250
– – 0.01% 357
2015
Q3 		$205K Buy
+250
New +$282K 0.01% 369

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Weiss Multi-Strategy Advisers's SRRA Position: Q3 2022 in Review

Weiss Multi-Strategy Advisers sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 18,648 shares — an estimated $1.02M sold.

Weiss Multi-Strategy Advisers first reported a position in SRRA in Q3 2015 and held it in 3 quarters. The position peaked at $1.02M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 18,648 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.02M.
  • Weiss Multi-Strategy Advisers first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Sierra Oncology, Inc. Common Stock position peaked at $1.02M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.